Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2603567 | 0.95 | L3MBTL1 (0.35) | L3MBTL1MEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL2603568 | 0.93 | MEN1 (0.36) | L3MBTL1MEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL31853 | 0.91 | L3MBTL1 (0.32) | L3MBTL1MEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL802107 | 0.90 | L3MBTL1 (0.35) | L3MBTL1MEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL24216248 | 0.89 | MEN1 (0.33) | L3MBTL1MEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL2603603 | 0.89 | MEN1 (0.33) | L3MBTL1MEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL18525886 | 0.89 | L3MBTL1 (0.31) | L3MBTL1MEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL18505531 | 0.89 | MEN1 (0.33) | L3MBTL1MEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL15625659 | 0.89 | MEN1 (0.33) | L3MBTL1MEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL2603576 | 0.88 | ABCG2 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230172045-A1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THEREOF | LG DISPLAY CO., LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| US-20230172045-A1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THEREOF | LG DISPLAY CO., LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| US-20230172043-A1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THEREOF | LG DISPLAY CO., LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| US-20230172052-A1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THEREOF | LG DISPLAY CO., LTD (KR) | 2023-06-01 | — | — | US | disclosed |
| US-20230172043-A1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THEREOF | LG DISPLAY CO., LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| US-20230172052-A1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THEREOF | LG DISPLAY CO., LTD (KR) | 2023-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172052-A1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THEREOF | OCIAD1, APOL1, OCIAD2 | L3MBTL1 6/4885MEN1 1769/4885MAPT 594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.